Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer
| Image |  |
|---|---|
| Description | scientific article published on 07 June 2018 |
| Author/s |
author: J Pérez Fidalgo |
| Publication date | June 7, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |